Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Saved in:
| Title: | Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva. |
|---|---|
| Authors: | Faustini SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Jossi SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Perez-Toledo M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Shields AM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Allen JD; School of Biological Sciences, University of Southampton, Southampton, UK., Watanabe Y; School of Biological Sciences, University of Southampton, Southampton, UK.; Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK., Newby ML; School of Biological Sciences, University of Southampton, Southampton, UK., Cook A; Binding Site Group Ltd, Birmingham, UK., Willcox CR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Salim M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Goodall M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Heaney JL; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Marcial-Juarez E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Morley GL; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK., Torlinska B; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Wraith DC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Veenith TV; Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK., Harding S; Binding Site Group Ltd, Birmingham, UK., Jolles S; Immunodeficiency Centre for Wales, Cardiff, UK., Ponsford MJ; Immunodeficiency Centre for Wales, Cardiff, UK., Plant T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Huissoon A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., O'Shea MK; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK., Willcox BE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Crispin M; School of Biological Sciences, University of Southampton, Southampton, UK., Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Richter AG; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. |
| Source: | Immunology [Immunology] 2021 Sep; Vol. 164 (1), pp. 135-147. Date of Electronic Publication: 2021 May 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2567 |
|---|---|
| DOI: | 10.1111/imm.13349 |
